These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1314160)

  • 21. Increased resistance to hypoxic conduction block in sciatic nerves of diabetic rats: effects of extracellular glucose concentration and of aldose reductase inhibition.
    Carrington AL; Ettlinger CB; Tomlinson DR
    J Diabetes Complications; 1994; 8(1):33-9. PubMed ID: 8167385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aldose reductase inhibition protects diabetic and nondiabetic rat hearts from ischemic injury.
    Ramasamy R; Oates PJ; Schaefer S
    Diabetes; 1997 Feb; 46(2):292-300. PubMed ID: 9000707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modification of the glyoxalase system in streptozotocin-induced diabetic rats. Effect of the aldose reductase inhibitor Statil.
    Phillips SA; Mirrlees D; Thornalley PJ
    Biochem Pharmacol; 1993 Sep; 46(5):805-11. PubMed ID: 8373434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of aldose reductase inhibitors on glomerular prostaglandin production and urinary albumin excretion in experimental diabetes mellitus.
    Chang WP; Dimitriadis E; Allen T; Dunlop ME; Cooper M; Larkins RG
    Diabetologia; 1991 Apr; 34(4):225-31. PubMed ID: 1906023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impairment of type III group B Streptococcus-stimulated superoxide production and opsonophagocytosis by neutrophils in diabetes.
    Mazade MA; Edwards MS
    Mol Genet Metab; 2001 Jul; 73(3):259-67. PubMed ID: 11461193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aldose reductase inhibition improves altered glucose metabolism of isolated diabetic rat hearts.
    Trueblood N; Ramasamy R
    Am J Physiol; 1998 Jul; 275(1):H75-83. PubMed ID: 9688898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between erythrocyte aldose reductase activity and the width of skeletal-muscle capillary basement membrane in insulin-dependent diabetes mellitus.
    Hamada Y; Hammon K; Raskin P
    J Diabetes Complications; 1992; 6(4):242-6. PubMed ID: 1482782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of aldose reductase inhibition on resistance to ischemic conduction block in diabetic subjects.
    Price DE; Alani SM; Wales JK
    Diabetes Care; 1991 May; 14(5):411-3. PubMed ID: 1905621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relative roles of advanced glycation, oxidation and aldose reductase inhibition in the development of experimental diabetic nephropathy in the Sprague-Dawley rat.
    Soulis-Liparota T; Cooper ME; Dunlop M; Jerums G
    Diabetologia; 1995 Apr; 38(4):387-94. PubMed ID: 7796978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of granulocyte-colony stimulating factor on generation of oxygen-derived free radicals and myeloperoxidase activity in neutrophils from poorly controlled NIDDM patients.
    Sato N; Kashima K; Tanaka Y; Shimizu H; Mori M
    Diabetes; 1997 Jan; 46(1):133-7. PubMed ID: 8971093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of aldose reductase from human retina.
    Poulsom R
    Curr Eye Res; 1987 Mar; 6(3):427-32. PubMed ID: 3107906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Axonal transport and tissue contents of substance P in rats with long-term streptozotocin-diabetes. Effects of the aldose reductase inhibitor 'statil'.
    Robinson JP; Willars GB; Tomlinson DR; Keen P
    Brain Res; 1987 Nov; 426(2):339-48. PubMed ID: 2446712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Erythrocytic sorbitol contents in diabetic patients correlate with blood aldose reductase protein contents and plasma glucose levels, and are normalized by the potent aldose reductase inhibitor fidarestat (SNK-860).
    Asano T; Saito Y; Kawakami M; Yamada N; Sekino H; Hasegawa S;
    J Diabetes Complications; 2004; 18(6):336-42. PubMed ID: 15531183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of diabetic autonomic neuropathy with red blood cell aldose reductase activity.
    Gupta P; Verma N; Bhattacharya S; Mahdi AA; Usman K; Tiwari S; Bhardwaj K
    Can J Diabetes; 2014 Feb; 38(1):22-5. PubMed ID: 24485209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Attenuated neutrophil respiratory burst following acute hypoglycaemia in diabetic patients and normal subjects.
    Thomson GA; Fisher BM; Gemmell CG; MacCuish AC; Gallacher SJ
    Acta Diabetol; 1997 Dec; 34(4):253-6. PubMed ID: 9451468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment with an aldose reductase inhibitor can reduce the susceptibility of fast axonal transport following nerve compression in the streptozotocin-diabetic rat.
    Dahlin LB; Archer DR; McLean WG
    Diabetologia; 1987 Jun; 30(6):414-8. PubMed ID: 2445613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aldose reductase inhibition and glomerular abnormalities in diabetic rats.
    Daniels BS; Hostetter TH
    Diabetes; 1989 Aug; 38(8):981-6. PubMed ID: 2502460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of aldose reductase inhibitor Statil (ICI 128436) on the glucose over-utilization in kidney of diabetic rats.
    Sochor M; Kunjara S; McLean P
    Biochem Pharmacol; 1988 Sep; 37(17):3349-56. PubMed ID: 2969732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of aldose reductase inhibition on erythrocyte polyols and galactitol accumulation in diabetic patients.
    Airey CM; Price DE; Kemp JV; Perkins CM; Wales JK
    Diabet Med; 1989 Dec; 6(9):804-8. PubMed ID: 2533041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aldose reductase and diabetic retinopathy.
    Singh R; Dash D; Ansari FJ; Maurya OP; Singh VP
    Ann Ophthalmol; 1992 Nov; 24(11):420-2. PubMed ID: 1476398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.